Corvus Pharmaceuticals
CRVS
CRVS
37 hedge funds and large institutions have $18.9M invested in Corvus Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
1.25% less ownership
Funds ownership: 45.9% → 44.65% (-1.3%)
12% less funds holding
Funds holding: 42 → 37 (-5)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
37
Holding in Top 10
1
Calls
$10K
Puts
$1K
Top Buyers
| 1 | +$118K | |
| 2 | +$25.1K | |
| 3 | +$17.7K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$9.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$5.75K |
Top Sellers
| 1 | -$130K | |
| 2 | -$70.2K | |
| 3 | -$66.4K | |
| 4 |
CA
CHI Advisors
New York
|
-$41K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$18K |